HIV and hepatitis G virus/GB virus C co-infection: Beneficial or not?

Lancet Infectious Diseases

Volumn 5, Issue 8, 2005, Pages 464-465

  Mehrishi, J N ^a,b   Bakács, Tibor ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Cambridge Chronic Hepatitis AIDS New Treatment Strategy Development Initiative   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; NUCLEOTIDE; RNA;

AMINO ACID SEQUENCE; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; DISEASE COURSE; DOWN REGULATION; FLAVIVIRUS; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS BURSAL DISEASE VIRUS; LYMPHOCYTE; PERINATAL INFECTION; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION; SHORT SURVEY; SURVIVAL; T LYMPHOCYTE; VIREMIA; VIRUS GENOME; VIRUS HEPATITIS;

EID: 22544435853     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70171-7     Document Type: Letter

References (18)

1. JN Simons, TP Leary, GJ Dawson Isolation of novel virus-like sequences associated with human hepatitis Nat Med 1 1995 564 569
2. J Linnen, J Wages Jr, ZY Zhang-Keck Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent Science 271 1996 505 508
3. K Abe GB virus-C/hepatitis G virus Jpn J Infect Dis 54 2001 55 63
4. J Xiang, S Wünschmann, DJ Diekema Effect of coinfection with GB virus C on survival among patients with HIV infection N Engl J Med 345 2001 707 714
5. HL Tillmann, H Heiken, A Knapik-Botor Infection with GB virus C and reduced mortality among HIV-infected patients N Engl J Med 345 2001 715 724
6. JT Stapleton, CF Williams, J Xiang GB virus type C: a beneficial infection? J Clin Microbiol 42 2004 3915 3919
7. CF Williams, D Klinzman, TE Yamashita Persistent GB virus C infection and survival in HIV-infected men N Engl J Med 350 2004 981 990
8. J Xiang, SL George, S Wünschmann, Q Chang, D Klinzman, JT Stapleton Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1 Lancet 363 2004 2040 2046
9. V Stosor, S Wolinsky GB virus C and mortality from HIV infection N Engl J Med 345 2001 761 762
10. AK Van der Bij, N Kloosterboer, M Prins GB virus C coinfection and HIV-1 disease progression: the Amsterdam Cohort Study J Infect Dis 191 2005 678 685
11. ZL Brumme, KJ Chan, WW Dong No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy AIDS 16 2002 1929 1933
12. P Björkman, L Flamholc, A Naucler, V Molnegren, E Wallmark, A Widell GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality AIDS 18 2004 877 886
13. TR Sterling, T Pisell-Noland, JL Perez Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals J Infect Dis 191 2005 881 885
14. S Schuval, JC Lindsey, JT Stapleton GB virus C infection in children with perinatal human immunodeficiency virus infection Pediatr Infect Dis J 24 2005 417 422
15. DL Thomas, D Vlahov, HJ Alter Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection J Infect Dis 177 1998 539 542
16. T Bakács, JN Mehrishi Examination of the value of treatment of decompensated viral hepatitis patients by intentionally coinfecting them with an apathogenic IBDV and using the lessons learnt to seriously consider treating patients infected with HIV using the apathogenic hepatitis G virus Vaccine 23 2004 3 13
17. LK Csatary, R Schnabel, T Bakács Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine Anticancer Res 19 1999 629 633
18. T Bakács, JN Mehrishi Intentional superinfection of decompensated chronic viral hepatitis by avian infectious bursal disease virus shows promise Feb 9-12, 2002 International Symposium on Predictive Oncology and Intervention Strategies Paris, France http://www.cancerprev.org/Journal/Issues/26/101/996/ 4338 (accessed June 30, 2005)